SC-19220, a Prostaglandin E2 Antagonist, Inhibits Osteoclast Formation by 1,25-Dihydroxyvitamin D3 in Cell Cultures

Journal of Endocrinology - United Kingdom
doi 10.1677/joe.0.1610231
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Points: 1,25 Dihydroxyvitamin D3 in Psoriasis

BMJ
1986English

Analysis of 1,25-Dihydroxyvitamin D3 Receptors (VDR. In Basal Cell Carcinomas

American Journal of Pathology
Forensic MedicinePathology
1999English

Prevention of Autoimmune Diabetes in NOD Mice by 1,25 Dihydroxyvitamin D3

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1994English

Induction of Monocytic Differentiation and Bone Resorption by 1,25-Dihydroxyvitamin D3.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1983English

Synergistic Effect of 1,25-Dihydroxyvitamin D3 and Retinoic Acid in Inducing U937 Cell Differentiation.

Journal of Nutritional Science and Vitaminology
MedicineNutritionDietetics
1992English

Evidence for 1,25-Dihydroxyvitamin D3-Independent Transactivation by the Vitamin D Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Emerging Regulatory Paradigms for Control of Gene Expression by 1,25-Dihydroxyvitamin D3

Journal of Steroid Biochemistry and Molecular Biology
Molecular MedicineCell BiologyMolecular BiologyBiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2010English

Characterization of a Receptor-Like Protein for 1,25-Dihydroxyvitamin D3 in Rat Skin.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1980English

1,25-Dihydroxyvitamin D3 Inhibits the Differentiation and Migration of TH17 Cells to Protect Against Experimental Autoimmune Encephalomyelitis

PLoS ONE
Multidisciplinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy